Figure 4.Relationship between CBXs and immune subtypes across in gastric cancer in TISIDB. (A) CBX1; (B) CBX2; (C) CBX3; (D) CBX4; (E) CBX5; (F) CBX6; (G) CBX7; (H) CBX8. C1: wound healing (n = 129); C2: IFN-gamma dominant (n = 210); C3: inflammatory (n = 36); C4: lymphocyte depleted (n = 9); C6: TGF-β dominant (n = 7).
